Life insurance companies typically test for only two STDs: HIV and hepatitis B/C. Despite common fears that insurers run a full STD panel, the medical exam is not a comprehensive sexual health screening. The blood and urine samples collected during your application are checked for a limited set of conditions that insurers consider relevant to mortality risk.
HIV and Hepatitis Are the Standard Tests
The vast majority of life insurance companies test for HIV and hepatitis B and C. These are the only sexually transmitted infections routinely screened during the underwriting process. You’ll typically be asked to sign a specific HIV consent form before providing your samples, and if any result comes back positive, the insurer is required to notify you privately.
Other common STDs like chlamydia, gonorrhea, syphilis, herpes, and HPV are not part of standard life insurance testing. Insurers aren’t interested in infections that are easily treatable or don’t significantly affect life expectancy. HIV and hepatitis B/C make the cut because, left untreated, they can shorten lifespan considerably, which directly affects the insurer’s financial risk.
What Happens if You Test Positive for HIV
Testing positive for HIV does not automatically disqualify you from getting life insurance, though it will significantly affect your options. Most underwriting guidelines require that you be on antiretroviral treatment with a demonstrated track record of at least six months of adherence. An undetectable viral load is an absolute requirement at nearly every company that considers HIV-positive applicants. Your immune cell count also needs to be above a minimum threshold, and any serious additional health conditions will generally make coverage unavailable.
If you do qualify, expect to pay substantially higher premiums. The rating you receive depends on the type of policy (term vs. whole life), the length of coverage, your age, and whether you smoke. Smoking compounds the risk assessment on top of the HIV rating, potentially making premiums prohibitively expensive. Historically, placement rates for HIV-positive applicants have been low because of these elevated costs, though more applicants are getting approved as treatment outcomes improve and insurers update their models.
How Hepatitis B and C Affect Your Application
Hepatitis A and E, which spread through contaminated food or water, almost always resolve on their own and don’t concern insurers. Hepatitis B and C are the ones that matter because both can become chronic infections with serious long-term consequences.
Hepatitis C is the bigger concern from an underwriting perspective. After 20 years of chronic infection, roughly 20% of people develop liver cirrhosis. After 30 years, that number climbs above 40%. Insurers look at several factors when assessing hepatitis risk: your age, whether you have any other viral infections, your alcohol consumption, and liver enzyme levels that indicate how well your liver is functioning. If you’ve been successfully treated and cleared the virus, your chances of approval improve dramatically, though you may still face a higher rating than someone who was never infected.
Hepatitis B follows a similar underwriting logic. A past infection that resolved is viewed very differently from a chronic active infection. The key question for insurers is whether the virus is still active and whether there’s evidence of liver damage.
What the Blood and Urine Tests Actually Check
Your life insurance medical exam collects blood and sometimes urine samples, but STD screening is only a small piece of what they’re looking for. The primary purpose of these tests is to build a broad picture of your health and flag conditions that affect mortality risk. Insurers are checking cholesterol levels, blood sugar (for diabetes), liver and kidney function, nicotine and cotinine (to verify whether you smoke), and sometimes drug screens.
The samples you provide can be tested through either blood or urine depending on the insurer and what they’re screening for. HIV testing, for example, can be performed on blood, urine, or saliva samples depending on the company’s protocol. You won’t always know exactly which sample is being used for which test, but the consent form you sign will outline what’s being screened.
What Insurers Can and Cannot Share
If your test reveals HIV or hepatitis, the insurer must notify you of the result. They cannot share your medical information with other insurance companies in a way that identifies specific diagnoses. However, if your application is denied or rated up, that decision may be recorded in the MIB (Medical Information Bureau), a database that other insurers can access. The MIB entry uses coded information rather than specific diagnoses, but a flag on your file can prompt other companies to investigate further during their own underwriting process.
Your test results are not reported to your employer, your doctor (unless you authorize it), or any public health database by the insurer. The process is handled confidentially, and many applicants who are nervous about STD testing find that the scope of what’s actually screened is far narrower than they expected.